-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Crohn's disease (CD) is a chronic and devastating bowel disease that requires bowel resection in nearly 50% of patients within the first decade of illness
.
Surgery is not curative for CD, and postoperative recurrence is common
Crohn's disease (CD) is a chronic and devastating bowel disease that requires bowel resection in nearly 50% of patients within the first decade of illness
To this end, the researchers conducted a prospective observational study in which the authors included patients with Crohn's disease who underwent ileocolectomy between January 2016 and November 2018
.
The first postoperative ileocolonoscopy in all patients was performed 4-5 weeks after surgery
Results of the study showed that in a total of 84 ileocolonoscopies, no endoscopic complications occurred
.
The primary endoscopic findings at the first assessment were peri-anastomotic ulcers (10, 11.
Figure: Colonoscopy picture
The results of this study confirmed the safety of endoscopic examination 1 month after surgery in patients with CD
.
Nearly half of the patients developed anastomotic sporadic ulcers, which were associated with future postoperative recurrence
The results of this study confirmed the safety of endoscopic examination 1 month after surgery in patients with CD
Guo, Zhen.
ndoscopic Evaluation at 1 Month After Ileocolic Resection for Crohn's Disease Predicts Future Postoperative Recurrence and Is Safe.
Leave a Comment here